Alzheimer's Society comment on high court ruling that NICE must hand over the executable model used in the Alzheimer's drugs appraisal and pay costs
Published 9 May 2008
Understanding how NICE reached its decision to deny treatments to thousands of people in the early stages of Alzheimer's has been difficult when NICE has kept their calculations secret.
'We look forward to seeing the detailed assumptions behind the decision so we can have a real debate with NICE over our concerns that this appraisal has been flawed from the beginning.
'It is very disappointing that it has been necessary to spend precious time and money to go to court. The costs of the legal process alone could have paid for a thousand people newly diagnosed with Alzheimer's to have access to treatments for a whole year.
'We look forward to working with NICE and the Department of Health to ensure that in future the needs of people with dementia and their carers are fully recognised.'
Neil Hunt
Chief Executive
Alzheimer's Society
